Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hutchinson's Melanotic Freckle × Aminolevulinic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 19 Brain Neoplasms 10 Glioma 7 Glioblastoma 6 Carcinoma, Basal Cell 4 Precancerous Conditions 2 Mycosis Fungoides 2 Meningioma 2 Lymphoma, T-Cell, Cutaneous 2 Gliosarcoma 2 Basal Cell Nevus Syndrome 2 Urinary Bladder Neoplasms 1 Squamous Intraepithelial Lesions 1 Skull Base Neoplasms 1 Skin Neoplasms 1 Sezary Syndrome 1 Pituitary Neoplasms 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Nonmelanoma Skin Cancers 1 Neurofibromatoses 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Lymphoma 1 Leukoplakia 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1

Interventions

Imiquimod 2 Radiotherapy 1 Intravital Microscopy 1 Equipment and Supplies 1 BF-200 ALA 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02685592 2018-05-30

LM PDT

Joint Authority for Päijät-Häme Social and Health Care

Phase 4 Completed

Hutchinson's Melanotic Freckle

Data powered by HemOnc (CC BY 4.0) Colophon ⚡